| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028922362 |
| P356 | DOI | 10.1186/1476-4598-12-16 |
| P932 | PMC publication ID | 3599053 |
| P698 | PubMed publication ID | 23452820 |
| P5875 | ResearchGate publication ID | 235773924 |
| P50 | author | Charles Rudin | Q42609280 |
| Luigi Marchionni | Q52094524 | ||
| P2093 | author name string | Sara Murphy | |
| Christine L Hann | |||
| Irina Dobromilskaya | |||
| Eric E Gardner | |||
| Rebekah L Zinn | |||
| P2860 | cites work | Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells | Q39381980 |
| BH3 mimetics activate multiple pro-autophagic pathways | Q39565305 | ||
| Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737. | Q39860032 | ||
| Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells | Q39899983 | ||
| Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells | Q39910064 | ||
| Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells | Q40015691 | ||
| The anticancer drug imatinib induces cellular autophagy. | Q40165123 | ||
| Autophagy delays apoptotic death in breast cancer cells following DNA damage | Q40228732 | ||
| Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells | Q40600919 | ||
| Differential effects of the autophagy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-α-induced neutrophil apoptosis | Q41929456 | ||
| Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. | Q46060884 | ||
| Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. | Q50537316 | ||
| Expression of bcl-2 in small cell lung carcinoma cells. | Q54218040 | ||
| Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas | Q74619605 | ||
| BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L) | Q80167533 | ||
| Small-cell lung cancer | Q81354821 | ||
| Autophagy and cancer therapy | Q82997243 | ||
| Guidelines for the use and interpretation of assays for monitoring autophagy | Q21996341 | ||
| Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
| Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1 | Q24303558 | ||
| Patient-derived tumour xenografts as models for oncology drug development | Q24604068 | ||
| A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro | Q24647698 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy | Q28131727 | ||
| Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines | Q28469349 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen | Q29615061 | ||
| Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma | Q29622918 | ||
| A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles | Q32046208 | ||
| Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer | Q33326515 | ||
| Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors | Q33393931 | ||
| Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer | Q33400716 | ||
| The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells | Q34055891 | ||
| Autophagy: basic principles and relevance to disease | Q34585381 | ||
| Principles and current strategies for targeting autophagy for cancer treatment | Q34787732 | ||
| Autophagy as a therapeutic target in cancer. | Q35591562 | ||
| The role of autophagy in cancer development and response to therapy. | Q36251939 | ||
| The roles of therapy-induced autophagy and necrosis in cancer treatment | Q37038235 | ||
| The double-edged sword of autophagy modulation in cancer | Q37331327 | ||
| Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies | Q37616407 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| chloroquine | Q422438 | ||
| P304 | page(s) | 16 | |
| P577 | publication date | 2013-03-02 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer | |
| P478 | volume | 12 |
| Q34398390 | A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis |
| Q37712188 | ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer. |
| Q38770971 | ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells |
| Q26999216 | Autophagy in cancer |
| Q38787312 | Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells |
| Q36682355 | Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment |
| Q28543470 | Chloroquine is a zinc ionophore |
| Q36745823 | Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro |
| Q27307923 | Chloroquine-enhanced efficacy of cisplatin in the treatment of hypopharyngeal carcinoma in xenograft mice |
| Q38689955 | Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects |
| Q44431333 | Cytoprotective and nonprotective autophagy in cancer therapy |
| Q50755679 | Determination of glucose deficiency-induced cell death by mitochondrial ATP generation-driven proton homeostasis. |
| Q35613035 | Hypercapnia Inhibits Autophagy and Bacterial Killing in Human Macrophages by Increasing Expression of Bcl-2 and Bcl-xL. |
| Q34384711 | Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering |
| Q35852989 | Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers |
| Q26748741 | Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC? |
| Q35141879 | Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts |
| Q41911830 | Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy |
| Q92875466 | Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma in Vitro and Xenograft Mice Model |
| Q34402759 | Pharmacological regulators of autophagy and their link with modulators of lupus disease |
| Q38144288 | Role of autophagy in cancer prevention, development and therapy |
| Q41318193 | The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy |
| Q38198765 | Unravelling the multifaceted roles of Atg proteins to improve cancer therapy |
| Q88595072 | [Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1] |
Search more.